Advanced Tissue Sciences' skin replacement approved
This article was originally published in Clinica
Executive Summary
Advanced Tissue Sciences has received approval from the FDA to market its Dermagraft-TC temporary skin replacement in the US. The substitute skin is intended for people who are severely burned and in need of wound covering until their own skin can be grafted. Advanced Tissue Sciences, based in La Jolla, California, estimates that nearly 5,500 people die and at least 51,000 are hospitalised for burn treatment in the US each year.